Interestingly, TβRII expression is downregulated in metastatic HCC tissues and cell lines, and is associated with larger tumor size, poor differentiation, portal vein invasion, intrahepatic metastasis (IM), and shorter recurrence-free survival [102,103]. This evidence concerns the gene TGFBR2 and hepatocellular carcinoma.